A comprehensive review of everolimus clinical reports: a new mammalian target of rapamycin inhibitor.
about
Risk of Infectious Complications in Hemato-Oncological Patients Treated with Kinase InhibitorsCoronary microvasculopathy in heart transplantation: Consequences and therapeutic implications.What's new in clinical solid organ transplantation by 2013.New drugs, new challenges for dermatologists: mucocutaneous ulcers secondary to everolimus.Biotic acts of antibioticsOral intake of curcumin markedly activated CYP 3A4: in vivo and ex-vivo studies.Impact of the reduction of calcineurin inhibitors on renal function in heart transplant patients: a systematic review and meta-analysisAvoiding immunological rejection in regenerative medicine.Effect of mammalian target of rapamycin inhibitors on cytomegalovirus infection in kidney transplant recipients receiving polyclonal antilymphocyte globulins: a propensity score-matching analysis.Everolimus-based immunosuppression in liver transplant recipients: a single-centre experience.Everolimus-based immunosuppression in a case of ABO-incompatible liver transplantation with calcineurin inhibitor-related posterior occipital syndrome.Metabolic Reprogramming Commits Differentiation of Human CD27+IgD+ B Cells to Plasmablasts or CD27-IgD- Cells.Efficacy of everolimus with reduced-exposure cyclosporine in de novo kidney transplant patients at increased risk for efficacy events: analysis of a randomized trial.
P2860
Q26851417-D7258746-408B-41B3-99E9-E4F5D63AF41AQ33891755-33B0E05B-40BE-4146-BA6D-B747F19162E3Q34761349-42CACBF5-6B84-4E08-85D3-67E537249346Q35967285-B315D10A-5C62-4A00-9883-0064BC1F7230Q37101851-150B63EF-02EC-46D0-9C50-EDA8E2DBBFFFQ37734897-9FB4710A-5D3A-46E0-A9EE-4FE9B791C29DQ38164111-13BD265E-4286-448F-9523-B27E96934E83Q38453650-05790276-7B3A-46B7-9591-0B700896EBDFQ40483831-BACB7FDC-4015-4E35-AFDB-9E83BDD3782EQ40706040-A64479A6-4E15-4F32-9545-798FA3A131F9Q43642998-D14A0EBD-25FA-4F87-8851-A09B1539B7B1Q50579001-45E1345B-8B15-4C75-BF08-462FA9620FCBQ53599480-390C4AE8-D673-4544-89C5-B121BA5A7072
P2860
A comprehensive review of everolimus clinical reports: a new mammalian target of rapamycin inhibitor.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A comprehensive review of ever ...... target of rapamycin inhibitor.
@en
type
label
A comprehensive review of ever ...... target of rapamycin inhibitor.
@en
prefLabel
A comprehensive review of ever ...... target of rapamycin inhibitor.
@en
P2093
P1433
P1476
A comprehensive review of ever ...... target of rapamycin inhibitor.
@en
P2093
Cheryle Gurk-Turner
Matthew Cooper
Wana Manitpisitkul
P304
P356
10.1097/TP.0B013E31825B411C
P577
2012-10-01T00:00:00Z